Cargando…
Controversies in management of the bladder cuff at nephroureterectomy
Upper tract urothelial carcinoma (UTUC) accounts for roughly 5% of urothelial carcinomas. Historically, the gold standard for high-risk or bulky low-risk UTUC was an open radical nephroureterectomy with formal bladder cuff excision (BCE). The development of novel endoscopic, laparoscopic, and roboti...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475677/ https://www.ncbi.nlm.nih.gov/pubmed/32944551 http://dx.doi.org/10.21037/tau.2020.01.17 |
_version_ | 1783579559864565760 |
---|---|
author | Braun, Avery E. Srivastava, Abhishek Maffucci, Fenizia Kutikov, Alexander |
author_facet | Braun, Avery E. Srivastava, Abhishek Maffucci, Fenizia Kutikov, Alexander |
author_sort | Braun, Avery E. |
collection | PubMed |
description | Upper tract urothelial carcinoma (UTUC) accounts for roughly 5% of urothelial carcinomas. Historically, the gold standard for high-risk or bulky low-risk UTUC was an open radical nephroureterectomy with formal bladder cuff excision (BCE). The development of novel endoscopic, laparoscopic, and robotic techniques has transformed this operation, yet no level I evidence exists at present that demonstrates the superiority of one strategy over another. While new approaches to nephroureterectomy in the last decade have shifted the management paradigm to decrease the morbidity of surgery, controversy continues to surround the approach to the distal ureter and bladder cuff. Debate continues within the urologic community over which surgical approach is best when managing UTUC and how various approaches impact clinical outcomes such as intravesical recurrence, recurrence-free survival (RFS) and disease-specific mortality (DSM). When focusing on the existing treatment algorithm, key metrics of quality include (I) removal of the entire specimen en bloc, (II) minimizing the risk of tumor and urine spillage, (III) R0 resection, and (IV) water-tight closure allowing for early use of prophylactic intravesical chemotherapy. In the absence of robust evidence demonstrating a single superior approach, the urologic surgeon should base decisions on technical comfort and each patient’s particular clinical circumstance. |
format | Online Article Text |
id | pubmed-7475677 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-74756772020-09-16 Controversies in management of the bladder cuff at nephroureterectomy Braun, Avery E. Srivastava, Abhishek Maffucci, Fenizia Kutikov, Alexander Transl Androl Urol Review Article on Upper-Tract Urothelial Carcinoma: Current State and Future Directions Upper tract urothelial carcinoma (UTUC) accounts for roughly 5% of urothelial carcinomas. Historically, the gold standard for high-risk or bulky low-risk UTUC was an open radical nephroureterectomy with formal bladder cuff excision (BCE). The development of novel endoscopic, laparoscopic, and robotic techniques has transformed this operation, yet no level I evidence exists at present that demonstrates the superiority of one strategy over another. While new approaches to nephroureterectomy in the last decade have shifted the management paradigm to decrease the morbidity of surgery, controversy continues to surround the approach to the distal ureter and bladder cuff. Debate continues within the urologic community over which surgical approach is best when managing UTUC and how various approaches impact clinical outcomes such as intravesical recurrence, recurrence-free survival (RFS) and disease-specific mortality (DSM). When focusing on the existing treatment algorithm, key metrics of quality include (I) removal of the entire specimen en bloc, (II) minimizing the risk of tumor and urine spillage, (III) R0 resection, and (IV) water-tight closure allowing for early use of prophylactic intravesical chemotherapy. In the absence of robust evidence demonstrating a single superior approach, the urologic surgeon should base decisions on technical comfort and each patient’s particular clinical circumstance. AME Publishing Company 2020-08 /pmc/articles/PMC7475677/ /pubmed/32944551 http://dx.doi.org/10.21037/tau.2020.01.17 Text en 2020 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Review Article on Upper-Tract Urothelial Carcinoma: Current State and Future Directions Braun, Avery E. Srivastava, Abhishek Maffucci, Fenizia Kutikov, Alexander Controversies in management of the bladder cuff at nephroureterectomy |
title | Controversies in management of the bladder cuff at nephroureterectomy |
title_full | Controversies in management of the bladder cuff at nephroureterectomy |
title_fullStr | Controversies in management of the bladder cuff at nephroureterectomy |
title_full_unstemmed | Controversies in management of the bladder cuff at nephroureterectomy |
title_short | Controversies in management of the bladder cuff at nephroureterectomy |
title_sort | controversies in management of the bladder cuff at nephroureterectomy |
topic | Review Article on Upper-Tract Urothelial Carcinoma: Current State and Future Directions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475677/ https://www.ncbi.nlm.nih.gov/pubmed/32944551 http://dx.doi.org/10.21037/tau.2020.01.17 |
work_keys_str_mv | AT braunaverye controversiesinmanagementofthebladdercuffatnephroureterectomy AT srivastavaabhishek controversiesinmanagementofthebladdercuffatnephroureterectomy AT maffuccifenizia controversiesinmanagementofthebladdercuffatnephroureterectomy AT kutikovalexander controversiesinmanagementofthebladdercuffatnephroureterectomy |